Changes in formalin-evoked spinal Fos expression and nociceptive behaviour after oral administration of Bufferin A (aspirin) and L-5409709 (ibuprofen + caffeine + paracetamol)

Pain

Volumn 70, Issue 2-3, 1997, Pages 253-266

  Carrive, Pascal ^b   Meyer Carrive, Isabelle ^a  

^a ICP Firefly Pty Ltd   (Australia)

^b NONE

Author keywords

antinociception; c fos; formalin; NSAID; pain; spinal cord

Indexed keywords

ACETYLSALICYLIC ACID; CAFFEINE; FORMALDEHYDE; IBUPROFEN; L 5409709; PARACETAMOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; MALE; NONHUMAN; ONCOGENE C FOS; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; RAT; SPINAL CORD;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CAFFEINE; DRUG COMBINATIONS; FORMALDEHYDE; IBUPROFEN; IMMUNOHISTOCHEMISTRY; MALE; NOCICEPTORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; SPINAL CORD;

EID: 0030964776     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)03325-8     Document Type: Article

References (75)

1. Abbott, F.V., Franklin, K.B.J. and Westbrook, R.F., The formalin test: scoring properties of the first and second phases of the pain response in rats, Pain, 60 (1995) 91-102.
2. Björkman, R., Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol, experimental studies in the rat, Acta Anaesthesiol. Scand., 39 (Suppl. 103) (1995).
3. Björkman, R.L., Hedner, T., Hallman, K.M., Henning, M. and Hedner, J., Localization of the central antinociceptive effects of diclofenac in the rat, Brain Res., 590 (1992) 66-73.
4. Björkman, R., Hallman, K.M., Hedner, J., Hedner, T. and Henning, M., Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P, Pain, 57 (1994) 259-264.
5. Brogden, R.N., Non-steroidal anti-inflammatory analgesics other than salicylates, Drugs, 32 (Suppl. 4) (1986) 27-45.
6. Bullit, E., Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat, J. Comp. Neurol., 296 (1990) 517-530.
7. Buritova, J., Honoré, P., Chapman, V. and Besson, J.-M., Carrageenan oedema and spinal Fos-LI neurones are reduced by piroxicam in the rat, NeuroReport, 6 (1995a) 1257-1260.
8. Buritova, J., Honoré, P., Chapman, V. and Besson, J.-M., Concurrent reduction of inflammation and spinal Fos-LI neurons by systemic diclofenac in the rat, Neurosci. Lett., 188 (1995b) 175-178.
9. Carlson, K.H. and Jurna, I., Central analgesic effect of paracetamol manifested by depression of nociceptive activity in thalamic neurones of the rat, Neurosci. Lett., 77 (1987) 339-343.
10. Carlson, K.H., Monzel, W. and Jurna, I., Depression by morphine and the non-opioid analgesic agents, metamizol (dipyrone), lysine acetylsalicylate, and paracetamol, of activity in rat thalamus neurones evoked by electrical stimulation of nociceptive afferents, Pain, 32 (1988) 313-326.
11. Chapman, V. and Dickenson, A.H., The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat, Eur. J. Pharmacol., 219 (1992) 427-433.
12. Clissold, S.P., Aspirin and related derivatives of salicylic acid, Drugs, 32 (Suppl. 4) (1986a) 8-26.
13. Clissold, S.P., Paracetamol and phenacetin, Drugs, 32 (Suppl. 4) (1986b) 46-59.
14. Coderre, T.J. and Melzack, R., The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury, J. Neurosci., 12 (1992) 3665-3670.
15. Coderre, T.J., Fundytus, M.E., McKenna, J.E., Dalal, S. and Melzack, R., The formalin test: a validation of the weighted-scores method of behavioural pain rating, Pain, 54 (1993) 43-50.
16. Dickenson, A.H. and Sullivan, A.F., Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin, Pain, 30 (1987) 349-360.
17. Dragunow, M. and Faull, R., The use of c-fos as a metabolic marker in neuronal pathway tracing, J. Neurosci. Methods, 29 (1989) 261-265.
18. Drower, E.J., Stapelfeld, A., Mueller, R.A. and Hammond, D.L., The antinociceptive effects of prostaglandin antagonists in the rat, Eur. J. Pharmacol., 133 (1987) 249-256.
19. Dubuisson, D. and Dennis, S.G., The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats, Pain, 4 (1977) 161-174.
20. Ferreira, S.H., Prostaglandins, aspirin-like drugs and analgesia, Nat. N. Bio., 240 (1972) 200-203.
21. Ferreira, S.H., Lorenzetti, B.B. and Correa, M.A., Central and peripheral antialgesic action of aspirin-like drugs, Eur. J. Pharmacol., 53 (1978) 39-48.
22. Gogas, K.R., Presley, R.W., Levine, J.D. and Basbaum, A.I., The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behaviour and c-fos expression, Neuroscience, 42 (1991) 617-628.
23. Gogas, K.R., Levine, J.D. and Basbaum, A.I., Differential contribution of descending controls to the antinociceptive actions of Kappa and Mu opioids: an analysis of formalin-evoked c-Fos expression, J. Pharmacol. Exp. Ther., 276 (1996) 801-809.
24. Harris, J.A., Westbrook, R.F., Duffield, T.Q. and Bentivoglio, M., Fos expression in the spinal cord is suppressed in rats displaying conditioned hypoalgesia, Behav. Neurosci., 109 (1995) 320-328.
25. Herdegen, T., Kovary, K., Leah, J. and Bravo, R., Specific temporal and spatial distribution of Jun, Fos, and Krox-24 proteins in spinal neurons following noxious transsynaptic stimulation, J. Comp. Neurol., 313 (1991) 178-191.
26. Herdegen, T. and Zimmermann, M., Immediate early genes (IEGs) encoding for inducible transcriptions factors (ITFs) and neuropeptides in the nervous system: functional network for long-term plasticity and pain, Prog. Brain Res., 104 (1995) 299-321.
27. Honoré, P., Buritova, J. and Besson, J.-M., Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin, Eur. J. Pharmacol., 272 (1995a) 249-259.
28. Honoré, P., Buritova, J. and Besson, J.-M., Aspirin and acetaminophen reduced both Fos expression in rat lumbar spinal cord and inflammatory signs produced by carrageenin inflammation, Pain, 63 (1995b) 365-375.
29. Hunskaar, S. and Hole, K., The formalin test in mice: dissociation between inflammatory and non-inflammatory pain, Pain, 30 (1987) 103-114.
30. Hunskaar, S., Famser, O.B. and Hole, K., Acetylsalicylic acid, paracetamol and morphine inhibit behavioural responses to intrathecally administered substance P or capsaicin, Life Sci., 37 (1985) 1835-1841.
31. Hunt, S.P., Pini, A. and Evan, G., Induction of c-fos-like protein in spinal cord neurons following sensory stimulation, Nature, 328 (1987) 632-634.
32. Jasmin, L., Wang, H., Tarczy-Hornoch, K., Levine, J.D. and Basbaum, A.I., Differential effects of morphine on noxious stimulus-evoked Fos-like immunoreactivity in subpopulations of spinoparabrachial neurons, J. Neurosci., 14 (1994) 7252-7260.
33. Jurna, I. and Brune, K., Central effect of the non-steroid anti-inflammatory agents, indomethacin, ibuprofen and diclofenac, determined in C fibre-evoked activity in single neurones of the rat thalamus, Pain, 41 (1990) 71-80.
34. Jurna, I., Spohrer, B. and Bock, R., Intrathecal injection of acetylsalicylic acid, salicylic acid and indomethacin depresses C fibre-evoked activity in the rat thalamus and spinal cord, Pain, 49 (1992) 249-256.
35. Kehl, L.J., Gogas, K.R., Lichtblau, L., Pollock, C.H., Mayes, M., Basbaum, A.I. and Wilcox, G.L., The NMDA antagonist MK801 reduces noxious stimulus-evoked Fos expression in the spinal cord dorsal horn. In: M.R. Bond, J.E. Charlton and C.J. Woolf (Eds.), Pain Research and Clinical Management, Vol. 4, Proc. VIth World Congress on Pain, Elsevier, Amsterdam, 1991, pp. 307-311.
36. Llewellyn-Smith, I.J., Minson, J.B. and Pilowksy, P.M., Retrograde tracing with cholera toxin B-gold or immunocytochemically-detected cholera toxin B in central nervous system. In: P.M. Conn (Ed.), Methods in Neurosciences, Vol. 8, Neurotoxins, Academic Press, New York, 1992, pp. 180-201.
37. Malmberg, A.B. and Yaksh, T.L., Antinociceptive actions of spinal non-steroidal anti-inflammatory agents on the formalin test in the rat, J. Pharmacol. Exp. Ther., 263 (1992a) 136-146
38. Malmberg, A.B. and Yaksh, T.L., Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cylcooxygenase inhibition, Science, 257 (1992b) 1276-1278.
39. Malmberg, A.B. and Yaksh, T.L., Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction, Anesthesiology, 79 (1993) 270-281.
40. Malmberg, A.B. and Yaksh, T.L., Cylclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats, J. Neurosci., 15 (1995) 2768-2776.
41. Maslany, S., Crockett, D.P. and Egger, M.D., Organization of cutaneous primary afferent fibers projecting to the dorsal horn in the rat: WGA-HRP versus B-HRP, Brain Res., 569 (1992) 123-135.
42. McCormack, K., The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects, Drugs, 47 (Suppl. 5) (1994a) 28-45.
43. McCormack, K., Non-steroidal anti-inflammatory drugs and spinal nociceptive processing, Pain, 59 (1994b) 9-43.
44. Menetrey, D., Gannon, A., Levine, J.D. and Basbaum, A.I., Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation, J. Comp. Neurol., 285 (1989) 177-195.
45. Morgan, J.I. and Curran, T., Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun, Annu. Rev. Neurosci., 14 (1991) 421-451.
46. Okuyama, S. and Aihara, H., Hyperalgesic action in rats of intracerebro-ventricularly administered arachidonic acid, PGE2 and PGF2α: effects of analgesic drugs on hyperalgesia, Arch. Int. Pharmacodyn., 278 (1985) 13-22.
47. Oluyomi, A.O., Poole, S., Smith, T.W. and Hart, S.L., Antinociceptive activity of peptides related to interleukin-lb-(193-195), Lys-Pro-Thr, Eur. J. Pharmacol., 258 (1994) 131-138.
48. Pelissier, T., Alloui, A., Paeile, C. and Eschalier, A., Evidence of a central antinociceptive effect of paracetamol involving spinal 5-HT3 receptors, Neuropharmacol. Neurotoxicol., 6 (1995) 1546-1548.
49. Piletta, P., Porchet, H.C. and Dayer, P., Central analgesic effect of acetaminophen but not of aspirin, Clin. Pharmacol. Ther., 49 (1991) 350-354.
50. Presley, R.W., Menetrey, D., Levine, J.D. and Basbaum, A.I., Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord, J. Neurosci., 10 (1990) 323-335.
51. Rosland, J.H., Tjolsen, A., Maelhe, B. and Hole, K., The formalin test in mice: effect of formalin concentration, Pain, 42 (1990) 235-242.
52. Sagar, S.M., Sharp, F.R. and Curran, T., Expression of c-fos protein in brain: metabolic mapping at the cellular level, Science, 240 (1988) 1328-1331.
53. Sawynok, J. and Yaksh, T.L., Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action, Pharmacol. Rev., 45 (1993) 43-85.
54. Sawynok, J., Reid, A.R. and Doak, G.J., Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: involvement of noradrenergic mechanisms, Pain, 61 (1995) 203-213.
55. Sheng, M. and Greenberg, M.E., The regulation and function of c-fos and other immediate early genes in the nervous system, Neuron, 4 (1990) 477-485.
56. Shibata, M., Ohkubo, T., Takahashi, H. and Inoki, R., Modified formalin test: characteristic biphasic pain response, Pain, 38 (1989) 347-352.
57. Sugiura, Y., Lee, C.L. and Perl, E.R., Central projections of identified unmyelinated (C) afferent fibers innervating mammalian skin, Science, 234 (1986) 358-361.
58. Swett, J.E. and Woolf, C.J., The somatotopic organization of primary afferent terminals in the superficial laminae of the dorsal horn of the rat spinal cord, J. Comp. Neurol., 231 (1985) 66-77.
59. Taiwo, Y.O. and Levine, J.D., Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses, J. Neurosci., 8 (1988) 1346-1349.
60. Tavares, I., Lima, D. and Coimbra, A., Neurons in the superficial dorsal horn of the rat spinal cord projecting to the medullary ventrolateral reticular formation express c-fos after noxious stimulation of the skin, Brain Res., 623 (1993) 278-286.
61. Tjolsen, A., Lund, A. and Hole, K., Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems, Eur. J. Pharmacol., 193 (1991) 193-201.
62. Tjolsen, A., Berge, O.-G., Hunskaar, S., Rosland, J.H. and Hole, K., The formalin test: an evaluation of the method, Pain, 51 (1992) 5-17.
63. Todd, A.J., Spike, R.C., Brodbelt, A.R., Price, R.F. and Shehab, S.A.S., Some inhibitory neurons in the spinal cord develop c-fos-immunoreactivity after noxious stimulation, Neuroscience, 63 (1994) 805-816.
64. Tölle, T.R., Castro-Lopes, J.M., Evan, G. and Zieglgansberger, W., c-Fos induction in the spinal cord following noxious stimulation: prevention by opiates but not by NMDA antagonists. In: M.R. Bond, J.E. Charlton and C.J. Woolf (Eds.), Proc. VIth World Congress on Pain, Elsevier, Amsterdam, 1991, pp. 299-305.
65. Tsou, K., Lowitz, K.A., Hohmann, A.G., Martin, W.J., Hathaway, C.B., Bereiter, D.A. and Walker, J.M., Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist, Neuroscience, 70 (1996) 791-798.
66. Vasko, M.R., Prostaglandin-induced neuropeptide release from spinal cord, Prog. Brain Res., 104 (1995) 367-380.
67. Wheeler-Aceto, H. and Cowan, A., Standardization of the rat paw formalin test for the evaluation of analgesics, Psychopharmacology, 104 (1991) 35-44.
68. Wheeler-Aceto, H., Porreca, F. and Cowan, A., The rat paw formalin test: comparison of noxious agents, Pain, 40 (1990) 229-238.
69. White, D.M., Mechanism of prostaglandin E2-induced substance P release from cultured sensory neurons, Neuroscience, 70 (1996) 561-565.
70. Willer, J.-C., De Broucker, T., Bussel, B., Roby-Brami, A. and Harrewyn, J.-M., Central analgesic effect of ketoprofen in humans: electrophysiological evidence for a supraspinal mechanism in a double-blind and cross-over study, Pain, 38 (1989) 1-7.
71. Williams, S., Pini, A., Evan, G. and Hunt, S.P., Molecular events in the spinal cord following sensory stimulation. In: F. Cervero, G.J. Bennett and P.M. Headle (Eds.), Processing of Sensory Information in the Superficial Dorsal Horn of the Spinal Cord, Plenum, New York, 1989, pp. 273-310.
72. Woolf, C.J., A new strategy for the treatment of inflammatory pain: prevention or elimination of central sensitization, Drugs, 47 (Suppl. 5) (1994) 1-9.
73. Woolf, C.J. and King, A.E., Physiology and morphology of multireceptive neurons with C-afferent fiber inputs in the deep dorsal horn of the rat lumbar spinal cord, J. Neurophysiol., 58 (1987) 460-479.
74. Yaksh, T.L., Central and peripheral mechanisms for the analgesic action of acetylsalicylic acid. In: H.J.M. Barnett, J. Hirsch and J.F. Mustard (Eds.), Acetylsalicylic Acid: New Uses for an Old Drug, Raven, New York, 1982, pp. 137-151.
75. Zhang, R.X., Wang, R., Chen, J.Y. and Qiao, J.T., Effects of descending inhibitory system on the c-Fos expression in the rat spinal cord during formalin-induced noxious stimulation, Neuroscience, 58 (1994) 299-304.